Guidance

dTaP/IPV: PGD template

PGD template to support the national diphtheria, tetanus, pertussis and poliomyelitis vaccination programme.

Applies to England

Documents

Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV): patient group direction (PGD) template

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) is to support the administration of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) to individuals from 3 years 4 months to under 10 years of age, in accordance with the national immunisation programme, or for the management of cases and contacts of diphtheria, tetanus, pertussis or poliomyelitis from 3 years of age.

The dTaP/IPV PGD version 5.00 is valid from 1 November 2023 to 1 November 2025.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Updates to this page

Published 7 January 2016
Last updated 30 October 2023 + show all updates
  1. Added version 4.00 - see page 2 for change history.

  2. Added version 04.00 - see page 2 for change history.

  3. Added updated PGD v03.00 to include management of pertussis outbreak in school/nursery and removed DTaP/IPV as not currently marketed in the UK.

  4. Reviewed: updated to add management of cases and contacts.

  5. First published.

Sign up for emails or print this page